loading

Springworks Therapeutics Inc (SWTX) 最新ニュース

pulisher
Jun 18, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Given Average Rating of "Hold" by Brokerages - MarketBeat

Jun 18, 2025
pulisher
Jun 17, 2025

Assenagon Asset Management S.A. Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Jun 17, 2025
pulisher
Jun 17, 2025

(SWTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 16, 2025

SpringWorks Therapeutics (SWTX) Continues Strong Yearly Run, Showing Over 29% YTD Gain - Daily Chhattisgarh News

Jun 16, 2025
pulisher
Jun 16, 2025

Biotech Stocks To ConsiderJune 16th - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

FNY Investment Advisers LLC Purchases New Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Jun 16, 2025
pulisher
Jun 16, 2025

SpringWorks Therapeutics Announces Merger with Merck KGaA - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

SpringWorks Merger Moves Forward with Regulatory Clearances By Investing.com - Investing.com India

Jun 16, 2025
pulisher
Jun 16, 2025

SpringWorks Merger Moves Forward with Regulatory Clearances - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OPOF, PRA, SWTX, FLS on Behalf of Shareholders - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 15, 2025

HAPPY FATHER’S DAY and $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger: OPOF, PRA, SWTX and FLS - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 14, 2025

SpringWorks Therapeutics’ SWOT analysis: stock outlook amid Merck acquisition - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

SpringWorks Therapeutics, Inc. Stock Update: Steady Performance Amid Market Trends - Daily Chhattisgarh News

Jun 12, 2025
pulisher
Jun 11, 2025

Best Biotech Stocks To Research – June 9th - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Best Growth Stocks To Follow Now – June 9th - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

Squarepoint Ops LLC Cuts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Jun 08, 2025
pulisher
Jun 07, 2025

88,995 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by RFG Advisory LLC - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Jun 07, 2025
pulisher
Jun 06, 2025

Top Growth Stocks To Follow Now – June 4th - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Best Biotech Stocks Worth Watching – June 4th - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

(SWTX) Proactive Strategies - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire

Jun 03, 2025
pulisher
Jun 02, 2025

Nuveen Asset Management LLC Has $6.64 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

$HAREHOLDER NOTICE: The M&A Class Action Firm Continues To Investigate The Merger - Benzinga

Jun 01, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Acquires Shares of 9,719 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 31, 2025
pulisher
May 30, 2025

Promising Growth Stocks To Research – May 28th - Defense World

May 30, 2025
pulisher
May 29, 2025

ProShare Advisors LLC Acquires 5,503 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 29, 2025
pulisher
May 28, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Hold" by Analysts - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Deutsche Bank AG Purchases 19,540 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 28, 2025
pulisher
May 28, 2025

Merck, SpringWorks receive German antitrust approval for their deal - MLex

May 28, 2025
pulisher
May 28, 2025

Palisades Investment Partners LLC Purchases 12,154 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Bank of America Corp DE Reduces Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

SpringWorks Therapeutics (SWTX) Surged on Acquisition News - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New $351,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

May 27, 2025
pulisher
May 26, 2025

SpringWorks Gets CHMP Nod for Mirdametinib in Rare Disease - Nasdaq

May 26, 2025
pulisher
May 26, 2025

SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com

May 26, 2025
pulisher
May 26, 2025

142,300 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Bought by Zimmer Partners LP - MarketBeat

May 26, 2025
pulisher
May 25, 2025

SpringWorks Therapeutics’ SWOT analysis: biotech stock faces acquisition challenges - Investing.com

May 25, 2025
pulisher
May 25, 2025

Growth Stocks To Consider – May 23rd - Defense World

May 25, 2025
pulisher
May 25, 2025

Growth Stocks To ConsiderMay 23rd - MarketBeat

May 25, 2025
pulisher
May 25, 2025

(SWTX) Investment Analysis - news.stocktradersdaily.com

May 25, 2025
pulisher
May 25, 2025

SpringWorks Therapeutics receives positive CHMP opinion for Mirdametinib for the treatment of adult and paediatric patients with NF1-PN | Health & Wellbeing | Lifestyle - The Phoenix Newspaper UK

May 25, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):